Product Information
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.1738 per EA under NDC 33342013807. Its NADAC has been published 243 times since Nov 3, 2021.
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateStrength
600; 200; 300 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342013807
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204287On Market Since
9/13/2021
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 243 times since Nov 3, 2021, and over the history we have for it it has declined 83.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1738 per EA |
|---|---|
| All-time high | $7.0703 (Dec 15, 2021) |
| All-time low | $1.1460 (Jul 17, 2024) |
| 52-week high | $1.6592 |
| 52-week low | $1.1738 |
| Median price | $1.6745 |
| Average price | $2.9005 |
| Largest weekly change | -74.7% (Aug 23, 2023) |
| Weeks tracked | 243 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $1.1738 per EA (NDC 33342013807), effective Jun 24, 2026.
How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 83.4%. It has been tracked across 243 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
Since Nov 3, 2021, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.1460 (Jul 17, 2024) to a high of $7.0703 (Dec 15, 2021), with a median of $1.6745 per EA.
Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, but none are currently priced below it.
Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 33342013807) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification